Clinical Development expert, physician scientist, and manager/leader with >40 years of experience in pharmaceutical industry in preclinical research, clinical research and development, personalized medicine & genomics, medical affairs and marketing.
Assignments as Head of Development and in CMO positions since 2008 (Grünenthal Group, Glenmark Pharmaceuticals, small biotech companies).
Experienced in building, modernizing and re-shaping pharmaceutical development organizations with a good balance of strategic and hands-on management.
Responsible for 5 approvals of innovative products between 1998 and 2019.
-
at the companies Schering AG (Head of Clinical Development HK & CNS), Grünenthal GmbH (Head of Clinical Development, Chief Medical Officer), Glenmark Pharmaceuticals (Head of Clinical R&D & CMO) and in Consulting (4 years)
-
for NCEs & NBEs in a wide range of indications (including CNS with a focus on neurodegeneration, pain, cardiovascular, pulmonary, autoimmune diseases) and with a focus on rare diseases,
-
in preclinical research, pharmacogenomics, biomarker development and translational medicine,
-
from phase I to phase III, in phase IIIb and IV & non-interventional studies,
-
in the preparation of (successful) approval dossiers (also as a clinical expert), benefit assessments (HTAs) and the preparation and implementation of market launches,
-
in due diligence processes and the critical "deep dive" evaluation of portfolios.